Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,673 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Anti-CD22 CAR-T combined with anti-CD19 CAR-T cells in the treatment of relapsed or refractory acute B lymphocytic leukemia with severe cytokine release syndrome: two cases report and literature review].
Gao LL, Huang L, Wang N, Wang GX, Zhou XX, Li TJ, Hong ZY, Meng L, Zhou JF. Gao LL, et al. Among authors: meng l. Zhonghua Xue Ye Xue Za Zhi. 2019 Sep 14;40(9):780-782. doi: 10.3760/cma.j.issn.0253-2727.2019.09.016. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31648485 Free PMC article. Review. Chinese. No abstract available.
[Efficacy and safety of domestic dasatinib as second-line treatment for chronic myeloid leukemia patients in the chronic phase].
Chen YL, Wang L, Yan GL, Yang ZZ, Huang ZP, Zhang YS, Zhao Z, Wan CC, Bao Y, Xiang H, Yin H, Chen LF, Xiong YY, Meng L, Li WM. Chen YL, et al. Among authors: meng l. Zhonghua Xue Ye Xue Za Zhi. 2019 Feb 14;40(2):98-104. doi: 10.3760/cma.j.issn.0253-2727.2019.02.002. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 30831623 Free PMC article. Chinese.
[Prognostic significance of early molecular response after second-line treatment with dasatinib of chronic myeloid leukemia patients].
Chen YL, Meng L, Yan GL, Yang ZZ, Huang ZP, Zhang YS, Zhao Z, Wang CC, Bao Y, Xiang H, Yin H, Chen LF, Xiong YY, Wang L, Li WM. Chen YL, et al. Among authors: meng l. Zhonghua Xue Ye Xue Za Zhi. 2019 Jul 14;40(7):608-611. doi: 10.3760/cma.j.issn.0253-2727.2019.07.015. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 32397028 Free PMC article. Chinese. No abstract available.
[Effect of imatinib on the height of children with chronic myeloid leukemia in the chronic phase].
Zheng FY, Zhang Y, Zhang LQ, Liu BC, Meng L, Jin J, Liu HL, Sun ZM, Lin LE, Lei PC, Zhu XF, Ma HX, Lu ZS, Jiang H, Zhao YH, Lin H, Zhang X, Yang GP, Zhu HL, Chen SN, You Y, Li WM, Bai QX, Zhao XL, Li ZY, Shen XM, Zhang LP, Jiang Q. Zheng FY, et al. Among authors: meng l. Zhonghua Xue Ye Xue Za Zhi. 2020 Jul 14;41(7):545-551. doi: 10.3760/cma.j.issn.0253-2727.2020.07.003. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 32810960 Free PMC article. Chinese.
[Management of patients with hematological malignancies in outbreak areas of COVID-19 epidemic: our experience at Wuhan Tongji Hospital].
Xiao Y, Cao Y, Huang L, Zheng M, Meng FK, Huang W, Li CR, Huang M, Zhang YC, Zhang DH, Deng JN, Meng L, Sun HY, Tang Y, Li DJ, Wan Y, Xu L, Zhou JF. Xiao Y, et al. Among authors: meng fk, meng l. Zhonghua Xue Ye Xue Za Zhi. 2020 Jul 14;41(7):612-614. doi: 10.3760/cma.j.issn.0253-2727.2020.2020.07.016. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 32810973 Free PMC article. Chinese. No abstract available.
6,673 results